Publications by authors named "C Barragan"
Article Synopsis
- ABP 654 is a biosimilar to ustekinumab, sharing identical amino acid sequences and similar safety and pharmacokinetics in healthy individuals.
- A clinical study was conducted to compare the efficacy and safety of ABP 654 versus ustekinumab in patients with moderate-to-severe plaque psoriasis, focusing on improvements in psoriasis severity.
- Results showed no significant difference in efficacy (PASI improvement) between ABP 654 and ustekinumab, and both treatments exhibited similar safety and immunogenicity profiles.
The introduction of artificial intelligence (AI) in interventional radiology (IR) will bring about new challenges and opportunities for patients and clinicians. AI may comprise software as a medical device or AI-integrated hardware and will require a rigorous evaluation that should be guided based on the level of risk of the implementation. A hierarchy of risk of harm and possible harms are described herein.
View Article and Find Full Text PDFArtificial intelligence (AI) is rapidly evolving and has transformative potential for interventional radiology (IR) clinical practice. However, formal training in AI may be limited for many clinicians and therefore presents a challenge for initial implementation and trust in AI. An understanding of the foundational concepts in AI may help familiarize the interventional radiologist with the field of AI, thus facilitating understanding and participation in the development and deployment of AI.
View Article and Find Full Text PDFBackground: To summarize current evidence to report a comparative systematic review and meta-analysis of prostatic artery embolization (PAE) with transurethral resection of the prostate (TURP) and open simple prostatectomy (OSP) for the treatment of benign prostatic hyperplasia (BPH).
Methods: A systematic literature search was performed to identify studies published from inception until August 2021. The search terms used were (prostate embolization OR prostatic embolization) AND (prostatic hyperplasia OR prostatic obstruction) as well as the abbreviations of PAE and BPH.